Tradewinds Capital Management’s Globus Medical GMED Stock Holding History

Tradewinds Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-270	Closed	-$20K	–	563
2022 Q1	$20K	Hold	270	–	–	﹤0.01%	369
2021 Q4	$19K	Sell	270 -75	-22%	-$5.44K	﹤0.01%	386
2021 Q3	$26K	Hold	345	–	–	﹤0.01%	336
2021 Q2	$27K	Hold	345	–	–	﹤0.01%	335
2021 Q1	$21K	Hold	345	–	–	﹤0.01%	340
2020 Q4	$23K	Hold	345	–	–	0.01%	307
2020 Q3	$17K	Hold	345	–	–	﹤0.01%	322
2020 Q2	$16K	Hold	345	–	–	﹤0.01%	316
2020 Q1	$15K	Hold	345	–	–	﹤0.01%	297
2019 Q4	$20K	Hold	345	–	–	0.01%	299
2019 Q3	$18K	Hold	345	–	–	0.01%	287
2019 Q2	$15K	Hold	345	–	–	0.01%	310
2019 Q1	$17K	Hold	345	–	–	0.01%	302
2018 Q4	$15K	Hold	345	–	–	0.01%	314
2018 Q3	$20K	Hold	345	–	–	0.01%	316
2018 Q2	$17K	Hold	345	–	–	0.01%	328
2018 Q1	$17K	Hold	345	–	–	0.01%	323
2017 Q4	$14K	Hold	345	–	–	0.01%	376
2017 Q3	$10K	Hold	345	–	–	0.01%	394
2017 Q2	$11K	Hold	345	–	–	0.01%	382
2017 Q1	$10K	Buy	+345	New	+$9.42K	0.01%	396

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Tradewinds Capital Management's GMED Position: Q2 2022 in Review

Tradewinds Capital Management sold out of Globus Medical (GMED) in Q2 2022, closing a stake of 270 shares — an estimated $20K sold.

Tradewinds Capital Management first reported a position in GMED in Q1 2017 and held it in 21 quarters. The position peaked at $27K in Q2 2021. 364 funds tracked by Wall St. Rank hold GMED as of Q2 2022.

Tradewinds Capital Management reported no remaining Globus Medical position as of Q2 2022 after selling out during the quarter.
Tradewinds Capital Management sold 270 Globus Medical shares in Q2 2022, an estimated $20K.
Tradewinds Capital Management first reported a position in Globus Medical in Q1 2017 and held it in 21 quarters.
Tradewinds Capital Management's Globus Medical position peaked at $27K in Q2 2021.
364 funds tracked by Wall St. Rank held Globus Medical as of Q2 2022.

Based on Tradewinds Capital Management's 13F filing for Q2 2022, filed 21 Jul 2022.